Denali Therapeutics executive Alexander O. Schuth sold 2,768 shares at $23.44 each on September 1, 2026. The transaction leaves Schuth owning 278,995 Denali shares, giving investors the disclosed post-transaction ownership figure for the company’s COFO and secretary.

Key Highlights

  • The reported transaction price was $23.44 per share.
  • Alexander O. Schuth retained 278,995 Denali Therapeutics shares after the sale.
  • The share transaction occurred on September 1, 2026.

Denali Therapeutics Inc. (NASDAQ: DNLI) executive Alexander O. Schuth sold 2,768 shares in a transaction involving the company’s stock. Schuth serves as Denali’s COFO and secretary.

$23.44 Per-Share Sale Leaves 278,995 Shares

The transaction carried a price of $23.44 for each share sold. His disclosed ownership after the transaction stood at 278,995 shares. The reported figures cover the shares sold, the per-share transaction price and Schuth’s remaining Denali holdings. Schuth’s post-transaction position was therefore stated at 278,995 shares. The disclosed ownership figure follows the sale of 2,768 shares.